Breast Cancer - Targeting A Protein Called Cyclin D1 May Block The Expansion Of Cancerous Stem Cells
Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. A new study appearing in Clinical and Translational Science shows the mechanisms governing stem cell expansion in breast cancer (called Notch activity), and finds that therapy targeting a protein called cyclin D1 may block the expansion of cancerous stem cells. The study, conducted by Dr.
More: continued here
Filed under: Breast Cancer on November 7th, 2008